Research areas
Exploring the Frontiers of Cell Therapy, Regenerative Medicine, and Immune Modulation.
At JY BioMed, our research is centered around harnessing the body’s intrinsic capabilities to combat disease, regenerate tissues, and restore immune balance. We pursue pioneering science that may lead to transformative therapies across oncology, immunology, regenerative health, neurology, infectious diseases, and autoimmune disorders.
Immuno-Oncology
Developing cell-based and biologic therapies that enhance the immune system’s ability to detect and destroy cancer cells.
Neurological Disorders
Investigating innovative cell and exosome therapies aimed at modulating neuroinflammation and promoting neural repair.
Infectious Diseases
Leveraging innate immune platforms, we are investigating novel approaches to enhance host defenses against infections.
Regenerative Medicine and Aging Research
Harnessing the regenerative and anti-inflammatory potential of MSCs and exosomes.
Autoimmune Diseases
Exploring the potential of immune modulation platforms to regulate aberrant immune responses in autoimmune conditions.
Target Biologic Therapies
Through our biologics platform, pursuing the development of targeted therapeutics designed to improve precision in disease intervention.
Exosome Research and Applications
Aiming to standardize and optimize exosome platforms for cell-free therapeutic delivery.
Regulatory Disclaimer
Research areas described herein involve programs at various stages of discovery and development. Except for the UC-MSC platform currently under Phase 1 clinical evaluation, all other programs remain investigational and are not approved for clinical or commercial use.